Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details- No Records Found
Title Grant Type Focus Area Country Application Due Date Acute Lymphoblastic Leukemia Peer-to-Peer Education & SupportRelease Date:Education Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA Understanding healthcare disparities in Atopic Dermatitis and Alopecia Areata patientsRelease Date:Quality Improvement Inflammation & Immunology All Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast CancerRelease Date:Education Oncology USA ADVANCE: Global Awards for Advancing Chronic Pain ResearchRelease Date:Research Internal Medicine All Enhancing the Understanding of Health Maintenance in the Management of IBDRelease Date:Education Inflammation & Immunology USA Outpatient Management of COVID-19Release Date:Education Hospital Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Turkmenistan, Ukraine, United Kingdom, Uzbekistan Emerging Therapies in Alopecia Areata for Dermatologists - United StatesRelease Date:Education Inflammation & Immunology USA 2021/2022 Global NASH ASPIRERelease Date:Research Internal Medicine All Virtual Programs for Rheumatology EducationRelease Date:Education Inflammation & Immunology USA Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis (Global (excluding the US)Release Date:Education Inflammation & Immunology All 2021/2022 Global Obesity ASPIRERelease Date:Research Internal Medicine All